OrganaBio, LLC is a vertically integrated cell therapy contract development and manufacturing organization (CTDMO) headquartered in Miami, Florida, with cGMP manufacturing and cell processing facilities in Miami and San Diego and regional cell processing labs in San Francisco and Irvine. Through its wholly owned, FDA-registered subsidiaries – HemaCenter, LLC (adult leukapheresis) and GaiaGift, LLC (birth tissue and cord blood) – OrganaBio operates proprietary supply chains for ethically sourced human tissues and blood-derived cellular products. The combined platform delivers GMP isolated cells, clinical-sample processing including PBMC isolation, cell isolation and cryopreservation services, cGMP manufacturing for autologous and allogeneic cell therapies, process development, analytical testing, quality assurance, and regulatory support under a single quality framework, enabling cell therapy developers to accelerate the path from development to patient. For more information, visit www.organabio.com.